Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
fluocinolone acetonide annexin a1 small molecule NA drugbank Eczema[MeSHID:D004485]
Communicable Diseases[MeSHID:D003141]
Keloid[MeSHID:D007627]
Posterior eyeball segment structure[MeSHID:D057972]
Ear structure[MeSHID:D004423]
Affect (mental function)[MeSHID:D000339]
Dermatitis[MeSHID:D003872]
Infection[MeSHID:D007239]
Psoriasis[MeSHID:D011565]
Physiologic Intraocular Pressure[MeSHID:D007429]
Body tissue[MeSHID:D014024]
Dermatologic disorders[MeSHID:D012871]
Otitis Externa[MeSHID:D010032]
Hypertrophy[MeSHID:D006984]
Macular Edema
Cystoid[MeSHID:D008269]
Dermatitis
Atopic[MeSHID:D003876]
Hemorrhoids[MeSHID:D006484]
Seborrheic dermatitis of scalp[MeSHID:D063807]
Uveitis[MeSHID:D014605]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammation[MeSHID:D007249]		 NA approved,investigational,vet_approved inducer
fluocinolone acetonide annexin a2 small molecule NA drugbank Eczema[MeSHID:D004485]
Communicable Diseases[MeSHID:D003141]
Keloid[MeSHID:D007627]
Posterior eyeball segment structure[MeSHID:D057972]
Ear structure[MeSHID:D004423]
Affect (mental function)[MeSHID:D000339]
Dermatitis[MeSHID:D003872]
Infection[MeSHID:D007239]
Psoriasis[MeSHID:D011565]
Physiologic Intraocular Pressure[MeSHID:D007429]
Body tissue[MeSHID:D014024]
Dermatologic disorders[MeSHID:D012871]
Otitis Externa[MeSHID:D010032]
Hypertrophy[MeSHID:D006984]
Macular Edema
Cystoid[MeSHID:D008269]
Dermatitis
Atopic[MeSHID:D003876]
Hemorrhoids[MeSHID:D006484]
Seborrheic dermatitis of scalp[MeSHID:D063807]
Uveitis[MeSHID:D014605]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammation[MeSHID:D007249]		 NA approved,investigational,vet_approved inducer
fluocinolone acetonide annexin a3 small molecule NA drugbank Eczema[MeSHID:D004485]
Communicable Diseases[MeSHID:D003141]
Keloid[MeSHID:D007627]
Posterior eyeball segment structure[MeSHID:D057972]
Ear structure[MeSHID:D004423]
Affect (mental function)[MeSHID:D000339]
Dermatitis[MeSHID:D003872]
Infection[MeSHID:D007239]
Psoriasis[MeSHID:D011565]
Physiologic Intraocular Pressure[MeSHID:D007429]
Body tissue[MeSHID:D014024]
Dermatologic disorders[MeSHID:D012871]
Otitis Externa[MeSHID:D010032]
Hypertrophy[MeSHID:D006984]
Macular Edema
Cystoid[MeSHID:D008269]
Dermatitis
Atopic[MeSHID:D003876]
Hemorrhoids[MeSHID:D006484]
Seborrheic dermatitis of scalp[MeSHID:D063807]
Uveitis[MeSHID:D014605]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammation[MeSHID:D007249]		 NA approved,investigational,vet_approved inducer
fluocinolone acetonide annexin a4 small molecule NA drugbank Eczema[MeSHID:D004485]
Communicable Diseases[MeSHID:D003141]
Keloid[MeSHID:D007627]
Posterior eyeball segment structure[MeSHID:D057972]
Ear structure[MeSHID:D004423]
Affect (mental function)[MeSHID:D000339]
Dermatitis[MeSHID:D003872]
Infection[MeSHID:D007239]
Psoriasis[MeSHID:D011565]
Physiologic Intraocular Pressure[MeSHID:D007429]
Body tissue[MeSHID:D014024]
Dermatologic disorders[MeSHID:D012871]
Otitis Externa[MeSHID:D010032]
Hypertrophy[MeSHID:D006984]
Macular Edema
Cystoid[MeSHID:D008269]
Dermatitis
Atopic[MeSHID:D003876]
Hemorrhoids[MeSHID:D006484]
Seborrheic dermatitis of scalp[MeSHID:D063807]
Uveitis[MeSHID:D014605]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammation[MeSHID:D007249]		 NA approved,investigational,vet_approved inducer
fluocinolone acetonide annexin a5 small molecule NA drugbank Eczema[MeSHID:D004485]
Communicable Diseases[MeSHID:D003141]
Keloid[MeSHID:D007627]
Posterior eyeball segment structure[MeSHID:D057972]
Ear structure[MeSHID:D004423]
Affect (mental function)[MeSHID:D000339]
Dermatitis[MeSHID:D003872]
Infection[MeSHID:D007239]
Psoriasis[MeSHID:D011565]
Physiologic Intraocular Pressure[MeSHID:D007429]
Body tissue[MeSHID:D014024]
Dermatologic disorders[MeSHID:D012871]
Otitis Externa[MeSHID:D010032]
Hypertrophy[MeSHID:D006984]
Macular Edema
Cystoid[MeSHID:D008269]
Dermatitis
Atopic[MeSHID:D003876]
Hemorrhoids[MeSHID:D006484]
Seborrheic dermatitis of scalp[MeSHID:D063807]
Uveitis[MeSHID:D014605]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammation[MeSHID:D007249]		 NA approved,investigational,vet_approved inducer
fluocinolone acetonide glucocorticoid receptor small molecule Successful target TTD , drugbank , DGIDB Eczema[MeSHID:D004485]
Communicable Diseases[MeSHID:D003141]
Keloid[MeSHID:D007627]
Posterior eyeball segment structure[MeSHID:D057972]
Ear structure[MeSHID:D004423]
Affect (mental function)[MeSHID:D000339]
Dermatitis[MeSHID:D003872]
Infection[MeSHID:D007239]
Psoriasis[MeSHID:D011565]
Physiologic Intraocular Pressure[MeSHID:D007429]
Body tissue[MeSHID:D014024]
Dermatologic disorders[MeSHID:D012871]
Otitis Externa[MeSHID:D010032]
Hypertrophy[MeSHID:D006984]
Macular Edema
Cystoid[MeSHID:D008269]
Dermatitis
Atopic[MeSHID:D003876]
Hemorrhoids[MeSHID:D006484]
Seborrheic dermatitis of scalp[MeSHID:D063807]
Uveitis[MeSHID:D014605]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammation[MeSHID:D007249]		 NA approved,investigational,vet_approved agonist
fluocinolone acetonide glucocorticoid receptor small molecule Successful target TTD , drugbank , DGIDB Eczema[MeSHID:D004485]
Communicable Diseases[MeSHID:D003141]
Keloid[MeSHID:D007627]
Posterior eyeball segment structure[MeSHID:D057972]
Ear structure[MeSHID:D004423]
Affect (mental function)[MeSHID:D000339]
Dermatitis[MeSHID:D003872]
Infection[MeSHID:D007239]
Psoriasis[MeSHID:D011565]
Physiologic Intraocular Pressure[MeSHID:D007429]
Body tissue[MeSHID:D014024]
Dermatologic disorders[MeSHID:D012871]
Otitis Externa[MeSHID:D010032]
Hypertrophy[MeSHID:D006984]
Macular Edema
Cystoid[MeSHID:D008269]
Dermatitis
Atopic[MeSHID:D003876]
Hemorrhoids[MeSHID:D006484]
Seborrheic dermatitis of scalp[MeSHID:D063807]
Uveitis[MeSHID:D014605]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Inflammation[MeSHID:D007249]		 0.24 approved,investigational,vet_approved agonist
click here to return to the previous page